| Date |
Research Question / Title |
Unique ID |
Research Team |
|
June 30, 2022
|
Response to Long COVID: What are the programs or accommodations to current frameworks?
|
EOC220303 RR
|
EOC
|
|
June 20, 2022
|
What are long COVID's demands on the healthcare system, and its
severity of the illness?
|
EPM210602v002 RR
|
Epidemiology & Modelling
|
|
June 6, 2022
|
What is known about hybrid immunity to COVID-19?
|
INF220501 RR
|
Infectious Disease
|
|
May 24, 2022
|
When should post-COVID infected patients receive booster shots?
|
EOC220503 RR
|
EOC
|
|
May 11, 2022
|
Is there any association or links between COVID and interferonopathy or polymyositis?
|
EOC220502 RR
|
EOC
|
|
May 10, 2022
|
Is there an optimal interval between the administration of COVID-19 early intervention therapeutic products and COVID-19 vaccination?
|
EOC220501 RR
|
EOC
|
|
March 31, 2022
|
What is the incidence and duration of long COVID cases?
|
EPM210601v2 RR
|
Epidemiology & Modelling
|
|
March 10, 2022
|
What is the safety/efficacy of the Novavax COVID-19 vaccine?
|
EOC220302 RR
|
EOC
|
|
February 4, 2022
|
What are the harmful/adverse effects of multiple doses of COVID-19 mRNA vaccines?
|
EOC220103 RR
|
EOC
|
|
October 29, 2021
|
Long COVID: What does it mean for the healthcare system and programs to deal with it?
|
EOC021901v2 RR
|
EOC
|
|
October 7, 2021
|
What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population?
|
EOC210902 RR
|
EOC
|
|
April 21, 2021
|
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
|
EOC210302 RR
|
EOC
|
|
April 6, 2021
|
How to deliver remote ICU care for COVID-19 patients to avoid/prevent transfer from smaller communities to tertiary care hospitals
|
CC210301 RR
|
Critical Care
|
|
February 27, 2021
|
What is the final disposition of post-COVID patients who require chronic ventilation in the ICU?
|
CC011101 RR
|
Critical Care
|
|
February 4, 2021
|
Are there validated clinical prediction tools of which Covid-19 inpatients are most probable to require ICU level care?
|
EOC012001 RR
|
EOC
|
|
January 22, 2021
|
What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update]
|
EOC062201v2 RR
|
EOC
|
|
January 20, 2021
|
What is the duration of immunity for COVID-19 in previously infected patients?
|
INF090101v2 RR
|
Infectious Disease
|
|
January 13, 2021
|
What are the outcomes of ECMO and COVID, particularly in small centers?
|
EOC011101 RR
|
EOC
|
|
December 9, 2020
|
What are the predictors of mortality in hospitalized COVID-19 patients?
|
CC120402 RR
|
Critical Care
|
|
November 25, 2020
|
Are probiotics effective for prevention or therapy of respiratory tract infections in all ages?
|
EOC111201 RR
|
EOC
|
